ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patrick, C.
Right arrow Articles by Horn, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patrick, C.
Right arrow Articles by Horn, B.
Annals of Clinical and Laboratory Science, Vol 23, Issue 1, 39-46
Copyright © 1993 by Association of Clinical Scientists


Articles

Alterations in von Willebrand factor antigen in premature infants with respiratory distress syndrome and chronic lung disease

CH Patrick, J Lazarchick, and BS Horn

Elevated levels of von Willebrand Factor Antigen (vWF:Ag) may occur in the presence of endothelial injury, a component in the pathology of acute pulmonary insufficiency. The vWF:Ag levels were examined in 13 well infants (controls) and 20 infants with respiratory distress syndrome (RDS), nine of whom developed bronchopulmonary dysplasia (BPD). All infants were very low birth weight (730 to 1500 g) and premature (25 to 34 weeks estimated gestational age). Plasma samples were obtained at birth and weekly through 28 days of age and frozen at -70 degrees C. The vWF:Ag was quantified by the enzyme linked immunosorbent assay (ELISA) method for 138 plasma specimens; in addition, 77 samples were analyzed for multimer pattern by SDS-agarose (1.7 percent) electrophoresis and densitometric scanning. All groups had elevated mean levels of vWF:Ag, compared to adults. Although levels remained stable over the four week period, the group of infants with BPD had a significantly high mean level of vWF:Ag at 21 days than those groups without BPD (p < 0.05). Visual examination of vWF multimer patterns revealed absence of unusually large vWF multimers and triplet patterns suggestive of increased proteolytic degradation of von Willebrand factor. However, densitometer scanning revealed that samples with higher vWF:Ag levels (> 200 percent) had increased amounts of moderate to smaller sized multimers, regardless of presence or absence of BPD. It is our conclusion that von Willebrand factor antigen levels are nonspecifically elevated in premature infants and that chronic lung disease is associated with even higher plasma values, possibly owing to pulmonary endothelial injury.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association of Clinical Scientists.